UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
151.96
+1.25 (0.83%)
Mar 10, 2026, 3:52 PM EST
UCB SA Market Cap
UCB SA has a market cap or net worth of $58.37 billion as of March 11, 2026. Its market cap has increased by 62.60% in one year.
Market Cap
58.37B
Enterprise Value
58.23B
Revenue
9.09B
Ranking
n/a
PE Ratio
31.91
Stock Price
$151.96
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 58.37B, an increase of 4,761.45%. That is a compound annual growth rate of 13.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 58.37B | 9.66% |
| Dec 31, 2025 | 53.23B | 40.99% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 367.72M |
| Silence Therapeutics | 294.27M |
| CytoDyn | 290.91M |
| Vaxart | 177.30M |
| HST Global | 88.40M |
| BioStem Technologies | 87.58M |
| Nuo Therapeutics | 60.36M |
| Vicapsys Life Sciences | 48.56M |